---
document_datetime: 2023-09-21 17:09:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cayston-epar-all-authorised-presentations_en.pdf
document_name: cayston-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7463591
conversion_datetime: 2025-12-21 20:15:04.468498
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form                       | Route of Administration   | Packaging                                  | Package size                                        |
|-----------------|-----------------|------------|-------------------------------------------|---------------------------|--------------------------------------------|-----------------------------------------------------|
| EU/1/09/543/001 | Cayston         | 75 mg      | Powder and solvent for nebuliser solution | Inhalation use            | Powder: vial (glass) Solvent: ampoule (PE) | 84 vials + 88 ampoules                              |
| EU/1/09/543/002 | Cayston         | 75 mg      | Powder and solvent for nebuliser solution | Inhalation use            | Powder: vial (glass) Solvent: ampoule (PE) | 84 vials + 88 ampoules + 1 Altera Nebuliser Handset |